The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Cerebral Cavernous Malformation
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 62 (final count)
- Started
- Mar 17, 2022
- Main results expected
- Jun 30, 2025
- Fully finished
- Jun 30, 2025
- Results posted
- Oct 22, 2026
What counts as success
The trial's main goal(s), called the “primary outcome.”
Number of Participants With Treatment-emergent Adverse Events (TEAEs)
Measured over: Up to a maximum of 1201 days
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT05085561 · record last updated 2026-10-22 · checked 2026-11-09 15:47 UTC